Co-Diagnostics JV CoMira Secures 14,400-Sq Ft Saudi Manufacturing Lease
Co-Diagnostics’ CoMira joint venture finalized a lease for a 14,400-square-foot manufacturing facility in Saudi Arabia’s Sudair Industrial City designated for diagnostic instruments, laboratory testing equipment and medical consumables. This execution moves the project from planning into development, supporting a capital-efficient expansion strategy aligned with the Kingdom’s Vision 2030 goals for healthcare infrastructure and local supply-chain resilience.
1. Lease Execution and Facility Details
The CoMira joint venture executed a lease for an approximately 14,400-square-foot industrial facility in Sudair Industrial City, one of Saudi Arabia’s leading hubs. The site is designated for approved manufacturing activities, including diagnostic instruments, laboratory testing equipment and medical consumables under the Co-Dx PCR platform.
2. Strategic Alignment with Vision 2030
This lease marks the transition from approval to development phase, advancing localized manufacturing capabilities in line with Saudi Arabia’s Vision 2030 objectives. It underscores efforts to strengthen healthcare infrastructure, domestic production and supply-chain resilience within the Kingdom.
3. Manufacturing Scope and Regulatory Pathway
The turnkey facility will support Co-Dx PCR platform production, subject to FDA and Saudi regulatory clearances, potentially expediting commercial launch. Local manufacturing may unlock preferential government procurement for domestically produced diagnostics.
4. Capital-Efficient Expansion and Next Steps
By choosing a turnkey build, CoMira aims for rapid operational readiness over ground-up construction, reflecting a capital-efficient approach to international growth. The joint venture now prepares for facility commissioning, validation testing and securing remaining approvals.